{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:45:11Z","timestamp":1777484711818,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"The Mater Palliative Care Research Fund"},{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Cancer Control"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pain is common in cancer patients, particularly in the advanced stage of the disease with more than 70% prevalence. Despite research regarding cancer pain management, clinicians\u2019 ability to predict and manage patient pain remains a significant challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      This sub-study of a prospective, open label, dose individualization study, investigated how selected single nucleotide polymorphisms (SNPs) in the\n                      <jats:italic>KCNJ6, ARRB2, and BDNF<\/jats:italic>\n                      genes may affect fentanyl dose requirements and response. Fifty-six adult inpatients or outpatients of oncology and pallateive care services who met the eligibility criteria were recruited Administration of transdermal fentanyl was monitored, and participant characteristics (age, height, weight, type of cancer, liver and renal function, fentanyl dose) and pain scores (numerical rating scale) recorded. SNP genotyping was conducted using pyrosequencing (\n                      <jats:italic>KCNJ6<\/jats:italic>\n                      and\n                      <jats:italic>BDNF<\/jats:italic>\n                      ) and TaqMan assays (\n                      <jats:italic>ARRB2<\/jats:italic>\n                      ). Statistical analysis included patient characteristics, observed and expected genotype frequencies, genotype and fentanyl dose\/pain score, along with categories of low (\u22643.0\/10) or high (&gt;3.0\/10) pain scores and low (\u226450 mcg\/hr) or high fentanyl doses (&gt;50 mcg\/hr).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median fentanyl dose administered was 50 mcg\/hr, with a range of 12 to 300 mcg\/hr, with the mean pain score 3.0\/10.0 (SD:2.3). No association was found between patient characteristics, fentanyl dose, and pain score (\n                      <jats:italic>P<\/jats:italic>\n                      -values &gt;0.05) in the European and Asian population. No association was found for\n                      <jats:italic>KCNJ6<\/jats:italic>\n                      (rs2070995),\n                      <jats:italic>ARRB2<\/jats:italic>\n                      (rs34230287, rs3786047, rs1045280, rs2036657), and\n                      <jats:italic>BDNF<\/jats:italic>\n                      (rs7934165, rs10835210, rs1491850) in relation to dose and pain score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      These results may show no association between the SNPs examined in\n                      <jats:italic>KCNJ6<\/jats:italic>\n                      ,\n                      <jats:italic>ARRB2,<\/jats:italic>\n                      and\n                      <jats:italic>BDNF<\/jats:italic>\n                      with fentanyl dose or response in the population of the study, as this was the case for the subgroups of the population we were able to divide individuals in based on allele groups. This evidence may enhance existing studies, driving the ongoing advancement and refinement of gene-drug dosing guidelines.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10732748251372675","type":"journal-article","created":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:14:26Z","timestamp":1758327266000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["A Preliminary Prospective Study on the Association of Polymorphisms in\n                    <i>BDNF<\/i>\n                    ,\n                    <i>ARRB2<\/i>\n                    and\n                    <i>KCNJ6<\/i>\n                    and Response to Fentanyl for Pain Management in Advanced Cancer"],"prefix":"10.1177","volume":"32","author":[{"given":"John","family":"Prenzler","sequence":"first","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5354-8868","authenticated-orcid":false,"given":"Alison","family":"Haywood","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia"},{"name":"Mater Research Institute, University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi Sutherland","family":"G","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Zunk","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep Bista","family":"R","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip","family":"Good","sequence":"additional","affiliation":[{"name":"Mater Research Institute, University of Queensland, Brisbane, QLD, Australia"},{"name":"Department of Palliative Care, St Vincent\u2019s Private Hospital, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyn Griffiths","family":"R","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Hardy","sequence":"additional","affiliation":[{"name":"Mater Research Institute, University of Queensland, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7735-8110","authenticated-orcid":false,"given":"Larisa M","family":"Haupt","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, Genomics Research Centre, School of Biomedical Sciences, Queensland University of Technology, Brisbane, QLD, Australia"},{"name":"ARC Training Centre for Cell and Tissue Engineering Technologies, Queensland University of Technology, Brisbane, QLD, Australia"},{"name":"Max Planck Queensland Centre for the Materials Sciences of Extracellular Matrices, Brisbane, QLD, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098421"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2018.02.002"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2005.04.001"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12816"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnw317"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.08.026"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0072"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0022"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137179"},{"issue":"6","key":"e_1_3_7_11_2","first-page":"2368","article-title":"BDNF gene polymorphism and serum level correlate with liver function in patients with hepatitis B-induced cirrhosis","volume":"12","author":"Shu HC","year":"2019","unstructured":"Shu HC, Hu J, Jiang XB, Deng HQ, Zhang KH. BDNF gene polymorphism and serum level correlate with liver function in patients with hepatitis B-induced cirrhosis. Int J Clin Exp Pathol. 2019;12(6):2368-2380.","journal-title":"Int J Clin Exp Pathol"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.326"},{"key":"e_1_3_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(00)00258-8"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy152"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02198"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2149"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00470"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.5188"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.11.033"},{"issue":"2","key":"e_1_3_7_20_2","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory","volume":"23","author":"Cleeland CS","year":"1994","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23(2):129-138.","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-8-200710160-00010"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-011-1408-8"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae977"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.03.024"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2016-0082"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283386bda"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.017"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006818"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnab172"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2016.264986"},{"key":"e_1_3_7_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-019-0074-4"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111515"},{"key":"e_1_3_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchp.2022.100330"},{"key":"e_1_3_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2016.03.007"},{"key":"e_1_3_7_35_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2021-0139"}],"container-title":["Cancer Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748251372675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10732748251372675","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10732748251372675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:23:58Z","timestamp":1777386238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10732748251372675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":34,"alternative-id":["10.1177\/10732748251372675"],"URL":"https:\/\/doi.org\/10.1177\/10732748251372675","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/10732748251372675\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251372675\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251372675\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251372675\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251372675\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251372675\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/10732748251372675\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1073-2748","1526-2359"],"issn-type":[{"value":"1073-2748","type":"print"},{"value":"1526-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"article-number":"10732748251372675"}}